Evidence map›Paper›PMID 27686215›Full record

ArticleScientific reports2016

High expression of MAP7 predicts adverse prognosis in young patients with cytogenetically normal acute myeloid leukemia.

Lin Fu, Huaping Fu, Lei Zhou, Keman Xu, Yifan Pang, Kai Hu, Jing Wang, Lei Tian, Yuanyuan Liu, Jijun Wang and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. NAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Article
  5. Clinical Significance of MAP-7 and FOXC1 in Egyptian Acute Myeloid Leukemia Patients.Asian Pacific journal of cancer prevention : APJCP · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Observational
  11. Article
  12. Article
  13. Article
  14. TheThe Journal of cell biology · 2019
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Lin FuDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing, 100191, China.
Huaping FuDepartment of Nuclear Medicine, Chinese PLA General Hospital, Beijing, 100853, China.
Lei ZhouDepartment of Hematology, Chinese PLA General Hospital, Beijing, 100853, China.
Keman XuCollege of Medical Laboratory Science and Technology, Harbin Medical University, Daqing, 163319, China.
Yifan PangDepartment of Medicine, William Beaumont Hospital, Royal Oak, MI, 48073, USA.
Kai HuDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing, 100191, China.
Jing WangDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing, 100191, China.
Lei TianDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing, 100191, China.
Yuanyuan LiuDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing, 100191, China.
Jijun WangDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing, 100191, China.
Hongmei JingDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing, 100191, China.
Wenrong HuangDepartment of Hematology, Chinese PLA General Hospital, Beijing, 100853, China.
Xiaoyan KeDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing, 100191, China.
Jinlong ShiDepartment of Biomedical Engineering, Chinese PLA General Hospital, Beijing, 100853, China.
Peking University Third Hospital · CNChinese PLA General Hospital · CNPeking University · CNBeaumont Hospital, Royal Oak · USHarbin Medical University · CNXuzhou Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microtubule-associated protein 7 (MAP7) plays an important role in cancer cells. In this study, we identified the prognostic significance of MAP7 expression in cytogenetically normal acute myeloid leukemia (CN-AML) patients (aged <60 years) based on several microarray datasets. In the first group (n = 129), high MAP7 expression (MAP7

Identifiers

PMID27686215
PMCPMC5043276
OpenAlexW2526181227

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.